Feb 04, 2021
MEI Pharma Reports Second Quarter Fiscal Year 2021 Results and Operational Highlights
Jan 04, 2021
MEI Pharma Announces Expansion of Phase 1b Study Evaluating Zandelisib and Clinical Pipeline Update
Nov 09, 2020
MEI Pharma to Present at Two Upcoming Investor Healthcare Conferences
Oct 02, 2020
Kyowa Kirin and MEI Pharma Announce First Patient Dosed in Japanese Pivotal Phase 2 Study of Zandelisib in Patients with Indolent B-cell non-Hodgkin's Lymphoma
Sep 15, 2020
MEI Pharma Appoints Brian T. Powl As Senior Vice President, Marketing
Sep 02, 2020
MEI Pharma to Release 2020 Fiscal Year End Financial Results and Provide Corporate Update on September 9, 2020
Aug 04, 2020
MEI Pharma to Present at the BTIG Virtual Biotechnology Conference 2020
May 27, 2020
MEI Pharma to Present at the Jefferies Virtual Healthcare Conference
May 14, 2020
MEI Pharma and Kyowa Kirin Announces ME-401 Phase 1b Study to be Highlighted in a Presentation at the Virtual Edition of the 25th European Hematology Association Annual Congress
May 07, 2020
MEI Pharma Reports Fiscal Third-Quarter 2020 Results and Recent Corporate Highlights
Apr 14, 2020
MEI Pharma Appoints Cheryl Cohen, Product Launch and Commercialization Veteran, to its Board of Directors
Apr 14, 2020
MEI Pharma and Kyowa Kirin Announce Global License, Development and Commercialization Agreement for ME-401
Mar 31, 2020
MEI Pharma Announces Fast Track Designation Granted by U.S. FDA for ME-401 For the Treatment of Adult Patients with Relapsed or Refractory Follicular Lymphoma
Feb 06, 2020
MEI Pharma Reports Fiscal Second-Quarter 2020 Results and Operational Highlights
Dec 17, 2019
MEI Pharma Announces Pricing of Public Offering of Common Stock
Dec 16, 2019
MEI Pharma Announces Proposed Public Offering of Common Stock
Nov 12, 2019
MEI Pharma to Present at the Stifel 2019 Healthcare Conference
Nov 07, 2019
MEI Pharma Reports First Quarter Fiscal Year 2020 Results and Operational Highlights
Oct 03, 2019
MEI Pharma Announces Updated Clinical Data from ME-401 Phase 1b Study in Patients with Indolent B-cell Malignancies
Sep 23, 2019
MEI Pharma to Host Investor and Analyst Event on October 4, 2019